InsidersTradesSigma
Browse the complete record of transactions filed by Jan Wahlström, Chairman & CEO. Director active across 2 companies, notably Devyser Diagnostics AB. In total, 2 reports have been published. The latest transaction was disclosed on 18 February 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
2 of 2 declarations
Jan Wahlström is the Chairman & CEO of Devyser Diagnostics AB, a company specializing in medical diagnostics. He is responsible for the strategic direction and management of the company's operations. Under his leadership, Devyser has developed innovative solutions for diagnostics, thereby contributing to the improvement of healthcare.